Category: Latest News

Abbott Laboratories (NYSE:ABT) received an upgrade from Jefferies, which raised its rating to Buy from Hold, stating that the recent post-earnings decline in the stock was “too punitive” and not reflective of the company’s long-term prospects. Shares of Abbott fell over 8% after the healthcare giant released second-quarter results that were largely in line with…

Synopsys Inc. (NASDAQ:SNPS) reached a fresh 52-week high of $594.23, signaling growing investor confidence in the semiconductor design software leader. With a market cap of $91.83 billion, the stock has delivered a 21.36% year-to-date return, underpinned by strong fundamentals and continued demand across the tech sector. Synopsys maintains an impressive gross profit margin of 81.41%,…

Shares of Fastenal Company (NASDAQ:FAST) climbed to an all-time high of $46.19, capping a remarkable run for the industrial supply giant. The milestone reflects Fastenal’s solid financial trajectory and investor optimism, with the stock delivering a 36.27% total return over the past year and a 29.03% gain year-to-date. Despite technical signals pointing to potential overbought…

Veritex Holdings, Inc. (NASDAQ:VBTX), the parent of Veritex Community Bank, posted second-quarter earnings that beat Wall Street projections, sending its shares up 1.1% after the announcement. While revenue came in just shy of expectations, profitability and credit metrics remained solid. For the quarter ending June 30, 2025, the Dallas-based lender delivered adjusted earnings per share…

Pop Culture Group Co Ltd (NASDAQ:CPOP) saw its stock jump 25% following the announcement of its strategic entry into the cryptocurrency sector, with a rollout planned for July 2025. The Chinese cultural content and events company said it intends to embed crypto payment solutions into its core operations, aiming to reduce transaction costs and speed…

Mesoblast Ltd. (NASDAQ:MESO) saw its stock surge 25% after reporting the first commercial sales for Ryoncil, its newly launched treatment for pediatric steroid-refractory acute graft-versus-host disease (SR-aGvHD). The therapy generated $13.2 million in gross revenue during its first quarter on the U.S. market. Ryoncil, officially launched on March 28, 2025, is the first and only…

Shares of Telomir Pharmaceuticals Inc. (NASDAQ:TELO) soared 150% on Thursday after the biotech firm unveiled compelling preclinical results for its experimental cancer therapy, Telomir-1. The data suggest the company’s lead drug candidate may significantly outperform standard cancer treatments in reactivating silenced tumor suppressor genes. In recent laboratory studies, Telomir-1 was shown to restore the function…

Draganfly Inc. (NASDAQ:DPRO) saw its stock plummet 27% on Thursday after unveiling the pricing details of a $25 million registered direct offering, sparking investor concerns about dilution and valuation. The drone technology firm confirmed it has entered into a securities purchase agreement with institutional investors for the sale of 4,672,895 units, each priced at $5.35.…

Shares of Bit Digital Inc. (NASDAQ:BTBT) rose 4% after the crypto mining firm announced the acquisition of nearly 20,000 Ethereum (ETH), deepening its commitment to digital asset accumulation. The company disclosed that it used proceeds from a recently completed $67.3 million registered direct offering to institutional investors to purchase approximately 19,683 ETH. This brings its…

MEI Pharma, Inc. (NASDAQ:MEIP) saw its stock more than double following the announcement of a $100 million private placement aimed at building a Litecoin treasury reserve. This move makes MEI the first publicly traded company on a major U.S. exchange to hold Litecoin (LTC) as a core treasury asset. Headquartered in San Diego, MEI Pharma…